European drug regulator rejects Alzheimer’s drug Leqembi, citing safety concerns

The European Medicines Agency on Friday held its ground against anti-amyloid treatments, saying it will not recommend Eisai and Biogen’s Alzheimer’s drug Leqembi for approval …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Real-World Data on the RSV Vaccine for Older Adults

During last year’s respiratory virus season, newly approved vaccines for respiratory syncytial virus (RSV) were effective in preventing associated hospitalizations and more serious outcomes in

November 12, 2024

Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023 – Biotech Investments

Kuros Biosciences AG / Key word(s): Annual Results 13-March-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

March 14, 2024

A Crisis Curveball at the Cubs Game

Listen and subscribe/follow on Apple and Spotify so you don’t miss the next episode. And if you like what you hear, a five-star rating goes

July 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.